Skip to main content
Equibles

Akash Tehwari

Analyst

Jefferies

Equibles does not estimate personal net worth.

About Akash Tehwari

Akash Tehwari is recorded as Analyst at Jefferies. Akash Tehwari has spoken on 1 earnings call across 1 company, most recently for Neurocrine Biosciences Inc on July 30, 2026. The companies whose calls Akash Tehwari spoke on are classified in the Healthcare sector.

Akash Tehwari on recent calls

“Just, okay, a few questions on your obesity efforts. So for 2118, the CRF2F, what do you expect for monotherapy weight loss and muscle preservation in your Phase I trial when you get into obese patients?”
Analyst — Jefferies, Neurocrine Biosciences Conference Call and Webcast of Q2 2026 Financial Results ·

Affiliation history

  • Jefferies

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity